ADVANCED ENDOMETRIAL CANCER
Clinical trials for ADVANCED ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for ADVANCED ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced endometrial cancer: Triple-Drug combo trial launches
Disease control Not yet recruitingThis study tests whether adding a drug called EG-007 to the standard combination of lenvatinib and pembrolizumab is safe for people with advanced or recurrent endometrial cancer. About 28 adults whose cancer has returned after platinum chemotherapy will take part. The goal is to …
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: Evergreen Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 16:06 UTC
-
New combo therapy aims to slow advanced uterine cancer
Disease control Not yet recruitingThis phase 3 trial tests whether adding the drug EG007 to a standard two-drug therapy (lenvatinib plus pembrolizumab) helps people with advanced or recurrent endometrial cancer live longer without their cancer growing. About 450 adults whose cancer has returned after platinum che…
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE3 • Sponsor: Evergreen Therapeutics, Inc. • Aim: Disease control
Last updated May 17, 2026 16:03 UTC